Trans Genic Inc. (2342) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Cyfuse Biomedical KK

Kidswell Bio Corp.

SUSMED, Inc.

Chiome Bioscience, Inc.

Trans Genic Inc.

StemCell Institute

OncoTherapy Science, Inc.

Oncolys BioPharma, Inc.

Carna Biosciences, Inc.

MEDINET Co., Ltd.

Stella Pharma Corp.

Why is Trans Genic Inc. ?

Poor long term growth as Operating profit has grown by an annual rate -181.00% of over the last 5 years

Flat results in Dec 25

NET PROFIT(HY) At JPY -7.81 MM has Grown at -4,925.41%
INTEREST(HY) At JPY 23.45 MM has Grown at 24.75%
CASH AND EQV(HY) Lowest at JPY 4,453.89 MM

Risky - Negative Operating Profits

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 46.41%, its profits have fallen by -114.9%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Trans Genic Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Trans Genic Inc.

-100.0%

0.14

100.70%

Japan Nikkei 225

38.94%

1.30

28.24%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

5.32%

EBIT Growth (5y)

-181.00%

EBIT to Interest (avg)

21.33

Debt to EBITDA (avg)

Net Debt to Equity (avg)

0.05

Sales to Capital Employed (avg)

1.59

Tax Ratio

61.33%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

14.69%

ROE (avg)

9.76%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.47

EV to EBIT

-34.46

EV to EBITDA

30.22

EV to Capital Employed

0.50

EV to Sales

0.22

PEG Ratio

Dividend Yield

ROCE (Latest)

-1.44%

ROE (Latest)

-3.42%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -4.57% (YoY

PRE-TAX PROFIT(Q)

Highest at JPY 146.43 MM

NET PROFIT(Q)

At JPY -10.69 MM has Grown at 88.55%

-16What is not working for the Company

NET PROFIT(HY)

At JPY -7.81 MM has Grown at -4,925.41%

INTEREST(HY)

At JPY 23.45 MM has Grown at 24.75%

CASH AND EQV(HY)

Lowest at JPY 4,453.89 MM

DEBT-EQUITY RATIO (HY)

Highest at 13.02 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.03 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 8.13 times

Here's what is working for Trans Genic Inc.

Pre-Tax Profit

At JPY 146.43 MM has Grown at 790.3%

over average net sales of the previous four periods of JPY -21.21 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (JPY MM)

Pre-Tax Profit

Highest at JPY 146.43 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (JPY MM)

Net Profit

At JPY -10.69 MM has Grown at 88.55%

over average net sales of the previous four periods of JPY -93.36 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (JPY MM)

Raw Material Cost

Fallen by -4.57% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Trans Genic Inc.

Interest

At JPY 23.45 MM has Grown at 24.75%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv

Lowest at JPY 4,453.89 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at 13.02 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 4.03 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 8.13 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio